| PJIQX | RWIAX | PJIQX / RWIAX | |
| Total Expense Ratio | 0.80 | 1.51 | 53% |
| Annual Report Gross Expense Ratio | 0.87 | 1.51 | 58% |
| Fund Existence | 15 years | 24 years | - |
| Gain YTD | 19.285 | 15.218 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 881M | 160B | 1% |
| Annual Yield % from dividends | 1.99 | 0.73 | 272% |
| Returns for 1 year | 27.45 | 20.85 | 132% |
| Returns for 3 years | 52.79 | 49.70 | 106% |
| Returns for 5 years | 36.91 | 31.19 | 118% |
| Returns for 10 years | 47.60 | 102.34 | 47% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSHZX | 13.70 | 0.15 | +1.11% |
| NYLI Cushing® MLP Premier Class I | |||
| FSMAX | 116.33 | N/A | N/A |
| Fidelity Extended Market Index | |||
| ACIZX | 66.86 | N/A | N/A |
| Alger Capital Appreciation Instl Z-2 | |||
| BIPIX | 80.88 | N/A | N/A |
| ProFunds Biotechnology UltraSector Inv | |||
| TASVX | 22.54 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val Z | |||